A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child ...

ChristianaCare’s Gene Editing Institute says it has found a way to reverse chemotherapy resistance in one of the most common ...

In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have shown that disabling the ...

Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.

Researchers have mapped the regulatory elements that control the FOXP3 gene, which is implicated in maintaining balance in ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...

On October 29, 2025, 10x Genomics announced the launch of its next-generation Chromium Flex assay, designed to help ...

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...

DYAI READ THE FULL DYAI RESEARCH REPORT Dyadic Applied BioSolutions, Inc. (NASDAQ:DYAI) announced third quarter 2025 results on November 12th, 2025, and held a conference call to discuss them after ...